The thin filament protein cardiac troponin T (cTnT) is an important regulator of myofilament activation. Here we report a significant change in cardiac energetics in transgenic mice bearing the missense mutation R92Q within the tropomyosin-binding domain of cTnT, a mutation associated with a clinically severe form of familial hypertrophic cardiomyopathy. This functional domain of cTnT has recently been shown to be a crucial modulator of contractile function despite the fact that it does not directly interact with the ATP hydrolysis site in the myosin head. Simultaneous measurements of cardiac energetics using 31P NMR spectroscopy and contractile performance of the intact beating heart revealed both a decrease in the free energy of ATP hydrolysis available to support contractile work and a marked inability to increase contractile performance upon acute inotropic challenge in hearts from R92Q mice. These results show that alterations in thin filament protein structure and function can lead to significant defects in myocardial energetics and contractile reserve.
Maryam M. Javadpour, Jil C. Tardiff, Ilka Pinz, Joanne S. Ingwall
Title and authors | Publication | Year |
---|---|---|
The abnormalities of free fatty acid metabolism in patients with hypertrophic cardiomyopathy, a single-center retrospective observational study
Zhang K, Yuan Z, Wang S, Zhao S, Cui H, Lai Y |
BMC Cardiovascular Disorders | 2024 |
Suppression of lusitropy as a disease mechanism in cardiomyopathies
Marston S, Pinto JR |
Frontiers in Cardiovascular Medicine | 2023 |
Mechano-energetic uncoupling in hypertrophic cardiomyopathy: Pathophysiological mechanisms and therapeutic opportunities
Sequeira V, Waddingham MT, Tsuchimochi H, Maack C, Pearson JT |
Journal of Molecular and Cellular Cardiology Plus | 2023 |
Genotype-Driven Pathogenesis of Atrial Fibrillation in Hypertrophic Cardiomyopathy: The Case of Different TNNT2 Mutations
Pioner JM, Vitale G, Gentile F, Scellini B, Piroddi N, Cerbai E, Olivotto I, Tardiff J, Coppini R, Tesi C, Poggesi C, Ferrantini C |
Frontiers in physiology | 2022 |
Cardiac (31)P MR spectroscopy: development of the past five decades and future vision-will it be of diagnostic use in clinics?
Gupta A |
Heart Failure Reviews | 2022 |
Defects in the Proteome and Metabolome in Human Hypertrophic Cardiomyopathy
Previs MJ, O\u2019Leary TS, Morley MP, Palmer B, LeWinter M, Yob J, Pagani FD, Petucci C, Kim MS, Margulies KB, Arany Z, Kelly DP, Day SM |
Circulation. Heart failure | 2022 |
Altered Cardiac Energetics and Mitochondrial Dysfunctionin Hypertrophic Cardiomyopathy
S Ranjbarvaziri, KB Kooiker, M Ellenberger, G Fajardo, M Zhao, AS Roest, RA Woldeyes, TT Koyano, R Fong, N Ma, L Tian, GM Traber, F Chan, J Perrino, S Reddy, W Chiu, JC Wu, JY Woo, KM Ruppel, JA Spudich, MP Snyder, K Contrepois, D Bernstein |
Circulation | 2021 |
Complexity in genetic cardiomyopathies and new approaches for mechanism-based precision medicine
MJ Greenberg, JC Tardiff |
The Journal of General Physiology | 2021 |
Actinin BioID reveals sarcomere crosstalk with oxidative metabolism through interactions with IGF2BP2
FA Ladha, K Thakar, AM Pettinato, N Legere, S Ghahremani, R Cohn, R Romano, E Meredith, YS Chen, JT Hinson |
Cell Reports | 2021 |
Increased Myocardial Oxygen Consumption Precedes Contractile Dysfunction in Hypertrophic Cardiomyopathy Caused by Pathogenic TNNT2 Gene Variants
RY Parbhudayal, HJ Harms, M Michels, AC van Rossum, T Germans, J van der Velden |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2020 |
Moving beyond simple answers to complex disorders in sarcomeric cardiomyopathies: the role of integrated systems
AE Deranek, MM Klass, JC Tardiff |
Pflügers Archiv - European Journal of Physiology | 2019 |
The relation between sarcomere energetics and the rate of isometric tension relaxation in healthy and diseased cardiac muscle
G Vitale, C Ferrantini, N Piroddi, B Scellini, JM Pioner, B Colombini, C Tesi, C Poggesi |
Journal of Muscle Research and Cell Motility | 2019 |
Differences in microRNA-29 and Pro-fibrotic Gene Expression in Mouse and Human Hypertrophic Cardiomyopathy
Y Liu, J Afzal, S Vakrou, GV Greenland, CC Talbot, VB Hebl, Y Guan, R Karmali, JC Tardiff, LA Leinwand, JE Olgin, S Das, R Fukunaga, MR Abraham |
Frontiers in Cardiovascular Medicine | 2019 |
Allele-specific differences in transcriptome, miRNome, and mitochondrial function in two hypertrophic cardiomyopathy mouse models
Styliani Vakrou, Ryuya Fukunaga, D. Brian Foster, Lars Sorensen, Yamin Liu, Yufan Guan, Kirubel Woldemichael, Roberto Pineda-Reyes, Ting Liu, Jil Tardiff, Leslie Leinwand, Carlo G. Tocchetti, Theodore Abraham, Brian O'Rourke, Miguel A. Aon, M. Roselle Abraham |
JCI Insight | 2018 |
The homozygous K280N troponin T mutation alters cross-bridge kinetics and energetics in human HCM
N Piroddi, ER Witjas-Paalberends, C Ferrara, C Ferrantini, G Vitale, B Scellini, PJ Wijnker, V Sequiera, D Dooijes, C dos Remedios, S Schlossarek, MC Leung, A Messer, DG Ward, A Biggeri, C Tesi, L Carrier, CS Redwood, SB Marston, J van der Velden, C Poggesi |
The Journal of General Physiology | 2018 |
Ranolazine Prevents Phenotype Development in a Mouse Model of Hypertrophic CardiomyopathyCLINICAL PERSPECTIVE
R Coppini, L Mazzoni, C Ferrantini, F Gentile, JM Pioner, T Laurino, L Santini, V Bargelli, M Rotellini, G Bartolucci, C Crocini, L Sacconi, C Tesi, L Belardinelli, J Tardiff, A Mugelli, I Olivotto, E Cerbai, C Poggesi |
Circulation. Heart failure | 2017 |
Peroxisome proliferator-activated receptor-α expression induces alterations in cardiac myofilaments in a pressure-overload model of hypertrophy
CN Karam, CM Warren, M Henze, NH Banke, ED Lewandowski, RJ Solaro |
American journal of physiology. Heart and circulatory physiology | 2017 |
Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models
C Ferrantini, R Coppini, JM Pioner, F Gentile, B Tosi, L Mazzoni, B Scellini, N Piroddi, A Laurino, L Santini, V Spinelli, L Sacconi, PD Tombe, R Moore, J Tardiff, A Mugelli, I Olivotto, E Cerbai, C Tesi, C Poggesi |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2017 |
Cardiac Troponin and Tropomyosin: Structural and Cellular Perspectives to Unveil the Hypertrophic Cardiomyopathy Phenotype
MA Marques, GA de Oliveira |
Frontiers in physiology | 2016 |
Liver Kinase B1 complex acts as a novel modifier of myofilament function and localizes to the Z-disk in cardiac myocytes
SM Behunin, MA Lopez-Pier, RM Mayfield, CA Danilo, Y Lipovka, C Birch, S Lehman, JC Tardiff, CC Gregorio, JP Konhilas |
Archives of Biochemistry and Biophysics | 2016 |
Cardiac troponin structure-function and the influence of hypertrophic cardiomyopathy associated mutations on modulation of contractility
Y Cheng, M Regnier |
Archives of Biochemistry and Biophysics | 2016 |
In Vivo Cannulation Methods for Cardiomyocytes Isolation from Heart Disease Models
Z Jian, YJ Chen, R Shimkunas, Y Jian, M Jaradeh, K Chavez, N Chiamvimonvat, JC Tardiff, LT Izu, RS Ross, Y Chen-Izu, GC Fan |
PloS one | 2016 |
Myocardial energy depletion and dynamic systolic dysfunction in hypertrophic cardiomyopathy
JO Ormerod, MP Frenneaux, MV Sherrid |
Nature Reviews Cardiology | 2016 |
Sex-related differences in the associations between plasma free fatty acid levels and clinical features in patients with hypertrophic cardiomyopathy
C Yang, C Zhang, J Yuan, J Cui, S Liu, F Hu, W Yang, X Bi, S Qiao |
Biology of sex differences | 2016 |
Animal and in silico models for the study of sarcomeric cardiomyopathies
DJ Duncker, J Bakkers, BJ Brundel, J Robbins, JC Tardiff, L Carrier |
Cardiovascular Research | 2015 |
ADP-stimulated contraction: A predictor of thin-filament activation in cardiac disease
V Sequeira, A Najafi, PJ Wijnker, CG Remedios, M Michels, DW Kuster, J der Velden |
Proceedings of the National Academy of Sciences | 2015 |
Muscle dysfunction in hypertrophic cardiomyopathy: What is needed to move to translation?
C Poggesi, CY Ho |
Journal of Muscle Research and Cell Motility | 2014 |
Hypertrophic cardiomyopathy: a heart in need of an energy bar?
S Vakrou, MR Abraham |
Frontiers in physiology | 2014 |
Investigating the role of uncoupling of troponin I phosphorylation from changes in myofibrillar Ca(2+)-sensitivity in the pathogenesis of cardiomyopathy
AE Messer, SB Marston |
Frontiers in physiology | 2014 |
Clinical Phenotype and Outcome of Hypertrophic Cardiomyopathy Associated With Thin-Filament Gene Mutations
R Coppini, CY Ho, E Ashley, S Day, C Ferrantini, F Girolami, B Tomberli, S Bardi, F Torricelli, F Cecchi, A Mugelli, C Poggesi, J Tardiff, I Olivotto |
Journal of the American College of Cardiology | 2014 |
Mechanical and energetic properties of papillary muscle from ACTC E99K transgenic mouse models of hypertrophic cardiomyopathy
W Song, PG Vikhorev, MN Kashyap, C Rowlands, MA Ferenczi, RC Woledge, K MacLeod, S Marston, NA Curtin |
American journal of physiology. Heart and circulatory physiology | 2013 |
ENerGetIcs in hypertrophic cardiomyopathy: traNslation between MRI, PET and cardiac myofilament function (ENGINE study)
A Güçlü, T Germans, ER Witjas-Paalberends, GJ Stienen, WP Brouwer, HJ Harms, JT Marcus, AB Vonk, W Stooker, A Yilmaz, P Klein, JM Berg, J Kluin, FW Asselbergs, AA Lammertsma, P Knaapen, AC van Rossum, J der Velden |
Netherlands Heart Journal | 2013 |
WIF1 causes dysfunction of heart in transgenic mice
D Lu, W Dong, X Zhang, X Quan, D Bao, Y Lu, L Zhang |
Transgenic Research | 2013 |
Magnetic resonance imaging and spectroscopy of the murine cardiovascular system
A Akki, A Gupta, RG Weiss |
American journal of physiology. Heart and circulatory physiology | 2013 |
Myosin-driven rescue of contractile reserve and energetics in mouse hearts bearing familial hypertrophic cardiomyopathy-associated mutant troponin T is mutation-specific
H He, K Hoyer, H Tao, R Rice, J Jimenez, JC Tardiff, JS Ingwall |
The Journal of Physiology | 2012 |
Hypertrophic Cardiomyopathy: A Vicious Cycle Triggered by Sarcomere Mutations and Secondary Disease Hits
PJ Wijnker, V Sequeira, DW Kuster, J van der Velden |
Antioxidants & Redox Signaling | 2012 |
Mechanisms of disease: hypertrophic cardiomyopathy
N Frey, M Luedde, HA Katus |
Nature Reviews Cardiology | 2011 |
Compromised Myocardial Energetics in Hypertrophied Mouse Hearts Diminish the Beneficial Effect of Overexpressing SERCA2a
I Pinz, R Tian, D Belke, E Swanson, W Dillmann, JS Ingwall |
The Journal of biological chemistry | 2011 |
Thin Filament Mutations: Developing an Integrative Approach to a Complex Disorder
JC Tardiff, J Robbins, C Seidman, H Watkins |
Circulation research | 2011 |
Cardiac myosin heavy chain isoform exchange alters the phenotype of cTnT-related cardiomyopathies in mouse hearts
R Rice, P Guinto, C Dowell-Martino, H He, K Hoyer, M Krenz, J Robbins, JS Ingwall, JC Tardiff |
Journal of Molecular and Cellular Cardiology | 2010 |
Increased myofilament Ca2+-sensitivity and arrhythmia susceptibility
S Huke, BC Knollmann |
Journal of Molecular and Cellular Cardiology | 2010 |
Abnormal heart rate regulation in murine hearts with familial hypertrophic cardiomyopathy-related cardiac troponin T mutations
J Jimenez, JC Tardiff |
American journal of physiology. Heart and circulatory physiology | 2010 |
Removal of the Cardiac Troponin I N-terminal Extension Improves Cardiac Function in Aged Mice
BJ Biesiadecki, K Tachampa, C Yuan, JP Jin, PP de Tombe, RJ Solaro |
The Journal of biological chemistry | 2010 |
Decreased contractility due to energy deprivation in a transgenic rat model of hypertrophic cardiomyopathy
M Luedde, U Flögel, M Knorr, C Grundt, HJ Hippe, B Brors, D Frank, U Haselmann, C Antony, M Voelkers, J Schrader, P Most, B Lemmer, HA Katus, N Frey |
Journal of Molecular Medicine | 2009 |
Role of Animal Models in HCM Research
R Shephard, C Semsarian |
Journal of Cardiovascular Translational Research | 2009 |
Mechanical and Energetic Consequences of HCM-Causing Mutations
C Ferrantini, A Belus, N Piroddi, B Scellini, C Tesi, C Poggesi |
Journal of Cardiovascular Translational Research | 2009 |
The role of Akt/GSK-3beta signaling in familial hypertrophic cardiomyopathy
SW Luckey, LA Walker, T Smyth, J Mansoori, A Messmer-Kratzsch, A Rosenzweig, EN Olson, LA Leinwand |
Journal of Molecular and Cellular Cardiology | 2009 |
Insights into the kinetics of Ca2+-regulated contraction and relaxation from myofibril studies
R Stehle, J Solzin, B Iorga, C Poggesi |
Pflügers Archiv - European Journal of Physiology | 2009 |
Myofilament Calcium Sensitization Causes Susceptibility To Cardiac Arrhythmia
Franz Baudenbacher*, Tilmann Schober#, Jose Renato Pinto@, Veniamin Y. Sidorov*, Fredrick Hilliard#, R. John Solaro%, James D. Potter@, Björn C. Knollmann#& |
Journal of Clinical Investigation | 2008 |
Energy metabolism in heart failure and remodelling
JS Ingwall |
Cardiovascular Research | 2008 |
The familial hypertrophic cardiomyopathy-associated myosin mutation R403Q accelerates tension generation and relaxation of human cardiac myofibrils: Human cardiac myofibril mechanics and R403Q myosin
A Belus, N Piroddi, B Scellini, C Tesi, GD Amati, F Girolami, M Yacoub, F Cecchi, I Olivotto, C Poggesi |
The Journal of Physiology | 2008 |
Late gadolinium enhancement cardiovascular magnetic resonance in genotyped hypertrophic cardiomyopathy with normal phenotype
B Strijack, V Ariyarajah, R Soni, DS Jassal, CR Greenberg, R McGregor, A Morris |
Journal of Cardiovascular Magnetic Resonance | 2008 |
R-92L and R-92W mutations in cardiac troponin T lead to distinct energetic phenotypes in intact mouse hearts
H He, MM Javadpour, F Latif, JC Tardiff, JS Ingwall |
Biophysical Journal | 2007 |
Differential effect of troponin T mutations on the inotropic responsiveness of mouse hearts - role of myofilament Ca 2+ sensitivity increase: Increasing myofilament Ca 2+ sensitivity limits inotropic responsiveness
SG Sirenko, JD Potter, BC Knollmann |
The Journal of Physiology | 2006 |
Functional consequence of mutation in rat cardiac troponin T is affected differently by myosin heavy chain isoforms: Troponin T mutation and tension cost
ML Tschirgi, I Rajapakse, M Chandra |
The Journal of Physiology | 2006 |
Myofibrillar remodelling in cardiac hypertrophy, heart failure and cardiomyopathies
Machackova J, Barta J, Dhalla NS |
The Canadian journal of cardiology | 2006 |
Sarcomeric Proteins and Familial Hypertrophic Cardiomyopathy: Linking Mutations in Structural Proteins to Complex Cardiovascular Phenotypes
JC Tardiff |
Heart Failure Reviews | 2005 |
Changes in the chemical and dynamic properties of cardiac troponin T cause discrete cardiomyopathies in transgenic mice
BR Ertz-Berger, H He, C Dowell, SM Factor, TE Haim, S Nunez, SD Schwartz, JS Ingwall, JC Tardiff |
Proceedings of the National Academy of Sciences | 2005 |
Structural based insights into the role of troponin in cardiac muscle pathophysiology
MX Li, X Wang, BD Sykes |
Journal of Muscle Research and Cell Motility | 2004 |
Two Functionally Identical Modular Enhancers in Drosophila Troponin T Gene Establish the Correct Protein Levels in Different Muscle Types
JA Mas, E García-Zaragoza, M Cervera |
Molecular biology of the cell | 2004 |
Cardiac troponin T and familial hypertrophic cardiomyopathy: an energetic affair
K Schwartz |
Journal of Clinical Investigation | 2003 |